Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer
Clinical trial NCT01388621 · UNKNOWN
Trial details
- NCT number
- NCT01388621
- Sponsor
- WiSP Wissenschaftlicher Service Pharma GmbH
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2014-07-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.